A company still losing money with shrinking sales.
Going well
No debt reported
Watch out for
Losing money
Revenue down 36% from the year before
Money moves
Insiders sold $226K in the last 30 days, all through pre-planned sales
Institutions cut 3.9% from their holdings in the quarter ending June 2026 (68 bought, 52 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$12.12+2.3% that day
Company value
$136M
Share price times all shares
Price vs sales
0.45x
No profit over the last year, so this compares value with sales instead
Cash vs value
43%
A big cushion: cash is a large part of what the company is worth
From MED's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Sep '26
$72.0M-19% vs a year earlier
Dec '23Tap a barSep '26
Last 12 months: $299.6M, down 30% from the 12 months before. Over 5 years, sales shrank about 16% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of MED. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$177M
Profit in 5 years$18M
Price these guesses point to$24.95+106% vs $12.12 todayAbout +16% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales could shrink about 22% a year for 5 years and still match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.